Bellevue Life Sciences Acquisition (BLAC) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Bellevue Life Sciences Acquisition Corp  (NASDAQ: BLAC)


Bellevue Life Sciences Acquisition's Gross Profit Margin by quarter

Trends, Rankings, Statistics



BLAC Gross Profit Margin (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Revenue Change -16.4 %
Seq. Revenue Change 66.25 %
Revenue In Millions $0.52
Gross Profit Margin 7.22 %
Gross Profit Margin Total Ranking # 2380
Gross Profit In Millions $0.04
Y / Y Gross Profit Change -85.52 %
Seq. Gross Profit Change -56.24 %


Commenting Third Quarter 2026 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 7.22 % due to increase in Cost of Sales and despite Revenue increase of 66.25 % to $1 millions.
Company's Gross Profit Margin in III. Quarter, was lower than company average.


Observing third quarter 2026 results within Medical Equipment & Supplies industry 146 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2380, from total ranking in the previous quarter at 2567.
Learn about Gross Margin
BLAC's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 147
Healthcare Sector # 374
Overall # 2360

Gross Profit Margin Statistics
High Average Low
41.69 % 23.7 % 3.17 %
(Sep 30 2025)   (Jun 30 2025)




Other Gross Profit Margin Profitability Ratios
BLAC's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BLAC's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BLAC's Competitors
Gross Profit Margin Profit Margin for Bellevue Life Sciences Acquisition's Suppliers
Gross Profit Margin Profit Margin for BLAC's Customers

You may also want to know
BLAC's Annual Growth Rates BLAC's Profitability Ratios BLAC's Asset Turnover Ratio BLAC's Dividend Growth
BLAC's Roe BLAC's Valuation Ratios BLAC's Financial Strength Ratios BLAC's Gross Profit Growth
BLAC's Roa BLAC's Inventory Turnover Ratio BLAC's Growth Rates BLAC's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
U S Physical Therapy Inc  19.34 %$ 43.032  Millions$ 222.558  Millions
The Pennant Group Inc   17.91 %$ 54.120  Millions$ 302.251  Millions
Yunhong Green Cti Ltd   10.59 %$ 0.331  Millions$ 3.127  Millions
EBR Systems, Inc.  10.01 %$ 0.249  Millions$ 2.487  Millions
Beyond Air Inc   8.48 %$ 0.197  Millions$ 2.324  Millions
Harvard Apparatus Regenerative Technology Inc   8.28 %$ 0.012  Millions$ 0.145  Millions
Bellevue Life Sciences Acquisition Corp  7.22 %$ 0.038  Millions$ 0.525  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.